123 related articles for article (PubMed ID: 38523535)
1. Readmission following methotrexate treatment for tubal pregnancy.
Bart Y; Regev N; Shani U; Cohen B; Yossef F; Margieh N; Kugelman N
Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38523535
[TBL] [Abstract][Full Text] [Related]
2. Expectant management of tubal pregnancies with human chorionic gonadotropin up to 2000 mIU/mL.
Kugelman N; Cohen B; Yossef F; Margieh N; Regev N; Shani U; Bart Y
Int J Gynaecol Obstet; 2024 Mar; 164(3):1094-1100. PubMed ID: 37776069
[TBL] [Abstract][Full Text] [Related]
3. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.
Jurkovic D; Memtsa M; Sawyer E; Donaldson AN; Jamil A; Schramm K; Sana Y; Otify M; Farahani L; Nunes N; Ambler G; Ross JA
Ultrasound Obstet Gynecol; 2017 Feb; 49(2):171-176. PubMed ID: 27731538
[TBL] [Abstract][Full Text] [Related]
4. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
[TBL] [Abstract][Full Text] [Related]
5. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction for treatment of tubal pregnancy using an intramuscular methotrexate protocol.
Moon MH; Lee YH; Lim KT; Yang JH; Park SH
J Ultrasound Med; 2008 Oct; 27(10):1461-7. PubMed ID: 18809956
[TBL] [Abstract][Full Text] [Related]
7. Predictors of methotrexate treatment failure in ectopic pregnancy.
Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
[TBL] [Abstract][Full Text] [Related]
8. Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success.
Wong L; Fung LWY; Cheung CW; Lao TT
Int J Gynaecol Obstet; 2018 May; 141(2):245-249. PubMed ID: 29214643
[TBL] [Abstract][Full Text] [Related]
9. Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling.
Cohen A; Bar-On S; Cohen Y; Sandel O; Fouks Y; Michaan N; Tzur T; Levin I
Reprod Sci; 2022 Apr; 29(4):1209-1214. PubMed ID: 35157263
[TBL] [Abstract][Full Text] [Related]
10. Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate?
Kucera E; Schindl M; Klem I; Sam C; Hanzal E; Kölbl H; Leodolter S; Sliutz G
Gynecol Obstet Invest; 2000; 49(1):6-11. PubMed ID: 10629365
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
[TBL] [Abstract][Full Text] [Related]
12. A risk prediction model for medical treatment failure in tubal pregnancy.
Lee JH; Kim S; Lee I; Yun J; Yun BH; Choi YS; Lee BS; Seo SK
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():148-154. PubMed ID: 29727784
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and prediction of ectopic pregnancy rupture following methotrexate treatment: A retrospective cohort study.
Aiob A; Yousef H; Abu Shqara R; Mustafa Mikhail S; Odeh M; Lowenstein L
Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():181-185. PubMed ID: 37146508
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate treatment in progressive tubal ectopic pregnancies and hCG-related clinicosurgical implications.
Dogan A; Gulhan I; Uyar I; Ekin A; Gezer C; Bilgin M; Taner CE; Ertas IE
Kaohsiung J Med Sci; 2016 Jun; 32(6):317-22. PubMed ID: 27377845
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy.
Kim J; Jung YM; Lee DY; Jee BC
Obstet Gynecol Sci; 2017 Jan; 60(1):79-86. PubMed ID: 28217676
[TBL] [Abstract][Full Text] [Related]
16. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
17. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate.
Dudley PS; Heard MJ; Sangi-Haghpeykar H; Carson SA; Buster JE
Fertil Steril; 2004 Nov; 82(5):1374-8. PubMed ID: 15533363
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of the failure of methotrexate treatment by Days 1-4 serum β-hCG change and 48-hour pre-treatment increment inβ-hCG.
Zhou H
J Obstet Gynaecol; 2023 Dec; 43(1):2183824. PubMed ID: 36862104
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular methotrexate for tubal pregnancy.
el-Lamie IK; Shehata NA; Kamel HA
J Reprod Med; 2002 Feb; 47(2):144-50. PubMed ID: 11883354
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Successful Medical Management With Methotrexate in Unruptured Tubal Ectopic Pregnancy.
Ray A; Gaur A; Kumari S
Cureus; 2022 Nov; 14(11):e31923. PubMed ID: 36580082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
